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Introduction and Aims 
 
Zearalenone is a Fusarium mycotoxin which exerts estrogenic properties leading to reduced reproductive capabilities of several animal species. To alleviate the effect of 
this and other mycotoxins, mycotoxin detoxifiers are often mixed in animal feed. These detoxifiers bind or modify the mycotoxin in the intestinal tract leading to a 
reduced bioavailability of mycotoxins. Commercially available detoxifiers can be classified in organic and anorganic detoxifiers, of which smectites are the largest 
subgroup within the anorganic detoxifiers. However, most of them are not well characterized and their mycotoxin binding capacity can vary significantly according to 
literature. 
The aims of present study were to:  1/ Characterize the physico-chemical properties of 27 different mycotoxin detoxifiers  
                    2/ Correlate these characteristics with in vitro zearalenone binding capacities 
Results 
Figure 1 displays the segmentation of the additives based on the XRD-analysis and mineral fraction, 
the zearalenone binding is depicted in figure 2. The zearalenone binding of the smectite containing 
group was related to the physico-chemical properties using a multivariate linear regression model. 
The retained multivariate linear model included exchangeable K+ (p≤0.05), moisture content 
(p≤0.05) and mineral fraction (0.05≤p≤0.1), indicating a statistical relation of these parameters with 
the in vitro zearalenone binding (figure 3).  
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Materials and methods 
 
1/ Characterization of the mycotoxin detoxifiers 
Twenty-seven commercially available mycotoxin detoxifiers from Belgium and the Netherlands were 
characterized. This comprised X-ray diffraction (XRD)-profiling, cation exchange capacity (CEC) and 
exchangeable cation (Ca2+, Mg2+, Na+ and K+) analysis, mineral fraction, moisture content, pH and 
swelling volume. 
 
2/ In vitro binding of zearalenone 
A similar protocol as Sabater-Vilar et al. (2007) was used. In brief, 20 mg of binder was shaken for 4 
hours in 5 mL PBS-buffer (pH 2.5, 6.5 and 8). The buffer contained zearalenone in a concentration of 
200 ng/mL. Zearalenone content in the supernatans was determined according to De Baere et al. 
(2012) with a modified sample clean-up procedure. The % binding was calculated as follows: (free 
concentration of zearalenone – total concentration)/total concentration  * 100%. 
Figure 1 ():  The XRD- and mineral fraction data were analyzed with 
principal component analysis and explorative cluster analysis which 
enabled the identification of three distinct groups: smectite based (n=18), 
non-smectite based (n=5) and organic based detoxifiers (n=4). 
Figure 2 (): In vitro binding of zearalenone to 27 commercially available mycotoxin detoxifiers. The % binding was calculated as follows: (free concentration of zearalenone – total 
concentration)/total concentration  * 100%. 
 
Figure 3 (): Observed binding vs. predicted binding of zearalenone according to the selected 
model, for pH 2.5, 6.5 and 8. This model includes exchangeable potassium, moisture content and 
mineral content. All the included parameters are fitted with a negative coefficient indicating an 
inverse correlation.  
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